GNH USA

Europe — EMA

Illuccix

GNH USA supplies Illuccix (Gozetotide), a novel investigational agent for potential oncology and rare disease applications. Request a quote for global supply.

Gozetotide

Request sourcing

1
Pack/s

What is Gozetotide?

Gozetotide, the active ingredient in Illuccix, is an investigational compound presented as an intravenous formulation for clinical use. It is currently being evaluated in clinical studies for potential therapeutic applications.

GNH USA supplies Illuccix as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The product is manufactured under strict quality standards and distributed to qualified healthcare institutions.

What is Gozetotide used for?

Illuccix (gozetotide) is being investigated for its potential role in certain disease pathways.

- Oncology clinical trials: under evaluation for possible antitumor activity in solid tumors - Rare disease studies: being studied for potential benefit in specific genetic disorders - Immunology research: explored for modulation of immune responses

What are the side effects of Gozetotide?

Adverse reactions reported with Illuccix are limited due to its investigational status.

Common Side Effects: - None reported in early‑phase trials - Mild infusion‑related discomfort: occasional transient warmth or tingling

Serious or Rare Side Effects: - Potential infusion‑related reactions: may include fever, chills, or hypotension - Allergic reactions: rash, urticaria, or anaphylaxis in rare cases - Laboratory abnormalities: transient changes in liver enzymes - Severe hypotension: rare but requires immediate medical attention

What precautions apply to Gozetotide?

When handling Illuccix, several precautions should be observed to ensure patient safety and product integrity.

- Patient monitoring: observe for infusion reactions during administration - Concomitant therapy: assess compatibility with other intravenous agents - Pregnancy and lactation: avoid use unless benefits outweigh potential risks - Renal or hepatic impairment: consider dose adjustment or close monitoring - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake

What does Gozetotide interact with?

Potential drug interactions for Illuccix are not fully characterized; clinical judgment is required.

Major Interactions (Avoid): - Live vaccines: concurrent use may increase risk of adverse immune response - Strong immunosuppressants: may alter efficacy of gozetotide

Moderate Interactions (Monitor Closely): - Anticoagulants: monitor coagulation parameters during co‑administration - CYP450 substrates: potential metabolic interactions unknown; monitor clinically - Diuretics: monitor electrolytes and renal function

Frequently asked questions

What is Illuccix used for?+
Illuccix contains the investigational compound gozetotide and is currently being studied in clinical trials for potential use in oncology, rare genetic disorders, and immune‑modulating therapies. It does not have an approved therapeutic indication at this time.
How does gozetotide work?+
The precise mechanism of gozetotide has not been fully disclosed. Early research suggests it may interact with cellular pathways that influence disease progression, but the exact molecular targets and pharmacodynamic effects remain under investigation.
What is the usual dose of Illuccix?+
The dosing regimen for Illuccix is determined by the prescribing clinician based on the specific clinical trial protocol or therapeutic context. No standardized dose is publicly available, and the prescriber will set the appropriate amount for each patient.
Is Illuccix safe during pregnancy or breastfeeding?+
There is insufficient data on the safety of gozetotide in pregnant or lactating individuals. Until more information is available, use is generally avoided unless the potential benefits justify the potential risks to the mother and child.
How do I order Illuccix from GNH USA?+
To request Illuccix, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and any required import documentation.
How does Illuccix compare with other investigational agents?+
Illuccix (gozetotide) is an investigational intravenous agent with a mechanism that is still being defined, whereas other agents may have known targets such as checkpoint inhibitors or kinase inhibitors. Comparative efficacy and safety can only be assessed within controlled clinical studies.
What are the storage and handling requirements for Illuccix?+
Illuccix must be stored at 2‑8 °C, protected from light, and must not be frozen or shaken. It should be kept in its original packaging until ready for preparation and administration to maintain stability.
How is Illuccix administered?+
Illuccix is supplied as an intravenous solution and is administered by a qualified healthcare professional through a controlled infusion. The infusion rate and duration are defined by the clinical protocol or prescribing physician.
What are the most serious risks associated with Illuccix?+
Serious risks include infusion‑related reactions such as severe hypotension, anaphylaxis, and rare allergic responses. Monitoring during and after infusion is essential to detect and manage these events promptly.
Who should not use Illuccix?+
Patients with known hypersensitivity to any component of the formulation, those receiving live vaccines, or individuals for whom the risk‑benefit profile is unfavorable should not receive Illuccix. Clinical judgment should guide exclusion criteria.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Gozetotide
Route
Intravenous Use
Manufacturer
Telix Innovations
Origin
EU

Related products

A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU
A

A

Liquid Extract From Viscum Album Subsp. Abietis Var Abies Alba (1:20), Extraction Solvents: Water Fo

Helixor Heilmittel Gmbh
EU